The HinduLean L·
Kilitch Drugs to divest Ethiopian arm for $14 million
The divestment will enable capital reallocation towards higher-growth opportunities in India, debt repayment and expansion of core pharmaceutical business
Read at The Hindu →
The divestment will enable capital reallocation towards higher-growth opportunities in India, debt repayment and expansion of core pharmaceutical business
<iframe src="https://hindustansphere.com/embed/cluster/a1b27408aa0fa6b019dc640d37750549d158e7dc" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Kilitch Drugs to divest Ethiopian arm for $14 million"></iframe>